An hour of management talk, in thirty seconds

Management claimed: Operating revenue increased by 31.34% to ₹70.36 crores in Q1 FY27, driven by robust execution and improved capacity utilization.

Management conceded: Management anticipates Q2 FY27 to be a low-volume monsoon quarter, potentially impacting revenue and margins compared to Q1.

Management claimed: Total income increased 19% YoY to INR2,134 million, demonstrating strong top-line growth.

Management conceded: Warehouse cost increased by 7% due to a one-time settlement for closing 3 warehouses.

Management claimed: Revenue grew 44% YoY to ₹973.45 crores, demonstrating strong demand across the portfolio.

Management claimed: Revenue for Q1 FY27 was ₹338.8 crores, representing a YoY growth of 35.2% compared with ₹250.6 crores in Q1 FY26.

Management conceded: EBITDA for Q1 FY27 was ₹33.8 crores, slightly down from ₹33.9 crores in Q1 FY26, resulting in a flat YoY growth.

Management claimed: Standalone total income increased by 6.6% quarter-on-quarter to INR173 crores.

Management conceded: EMOSS (European subsidiary) revenue declined to INR13.8 crores from INR29 crores in the previous quarter, with a cautious outlook due to slowdown in the electric commercial vehicle space and reduced program visibility.

Management claimed: Consolidated gross income increased 30% QoQ to INR 1,966 crores (from INR 1,516 crores in Q4 FY26).

Management conceded: Consolidated PBT decreased 15% QoQ to INR 157 crores (from INR 184 crores in Q4 FY26).

Management claimed: Achieved highest-ever quarterly revenue and EBITDA, with total income growing 79% YoY to INR 324 crores and EBITDA up 86% YoY to INR 294 crores.

Management conceded: Experienced 2-2.5% curtailment on a 50 MW merchant plant in Bikaner, though management is addressing this by doubling BESS capacity at the site.

Management claimed: Total income registered a robust 69.35% year-on-year growth to INR310.24 crores in Q1 FY27.

Management conceded: EBITDA margin declined to 6.34% in Q1 FY27 from 8.67% in Q1 FY26, attributed to product mix and raw material volatility.

Management claimed: Successful IPO and listing, providing crucial working capital.

Management conceded: Initial margin pressure expected during the production scale-up phase.

Management claimed: Revenue from operations grew 138% YoY to INR115.41 crores, driven by strong dredging performance.

Management claimed: Socks selling price per pair for Q1 FY27 reached ₹63, marking a 47% increase over the last two years.

Management conceded: The simultaneous integration of multiple new businesses and diverse product lines under the Brahmcorp umbrella presents potential management bandwidth and execution challenges.

Management claimed: Revenue increased by 11% Y-o-Y to approximately ₹51 crores.

Management conceded: Hardware prices have increased sharply (3x-4x) in the last year, posing a challenge for product procurement.

Management claimed: Revenue of INR 92.923 crores, up 37.26% YoY, driven by post-IPO projects.

Management conceded: Receivable days are 'a little high nowadays' due to pending final bills on three completed projects.

Management claimed: Consolidated turnover for Q1 FY27 grew 22% YoY to ₹132.6 crores, demonstrating strong overall performance.

Management conceded: Management noted persistent challenges from geopolitical conflicts and severe energy crises.

Management claimed: Strong revenue growth of 45% year-on-year to INR586.36 crores, driven by healthy momentum in both B2B and B2C operations.

Management claimed: Q1 FY27 Consolidated Revenue grew 17.74% YoY to ₹127 crores, demonstrating strong top-line expansion.

Management conceded: Debtor days remain high at 50-70 days, significantly above peers (8-10 days), though management has a plan to reduce them.

Management claimed: Consolidated Revenue for Q1 FY27 stood at ₹83.03 crores, a 56.6% YoY growth from ₹53.03 crores in Q1 FY26.

Management conceded: Inventory days increased due to shipping times from Europe (45-60 days) and recent geopolitical events (war), leading to higher inventory costs and risks.

Management claimed: Revenue from operations grew 15% YoY to INR304 crores in Q1 FY27.

Management conceded: FY26 was a difficult year for the cephalosporin business, with volumes and pricing affected by 15-20% declines.

Management claimed: Group console sales up ~38.5% YoY and ~17.5% QoQ to 186.5 crores, driven by automotive and metals segments.

Management conceded: Gross contributions declined by 145 bps sequentially and 181 bps YoY, attributed to commodity price pass-through, which optically erodes percentage margins.

Management claimed: Total revenue grew 13% year-on-year to INR 25,465 million, driven by strong demand in two and three-wheeler segments and new business wins.

Management conceded: EBITDA growth was 5% YoY (INR 2,933 million), lower than revenue growth, resulting in a slight margin compression to 11.5% from 12.4% in Q1 FY26.